Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of Pregnancy

Gastroenterology - Tập 133 - Trang 507-516 - 2007
Saskia W.C. van Mil1,2, Alexandra Milona1, Peter H. Dixon1, Roman Mullenbach1, Victoria L. Geenes1, Jenny Chambers1, Vasylyna Shevchuk1, Gudrun E. Moore3, Frank Lammert4, Anna G. Glantz5, Lars–Åke Mattsson5, John Whittaker6, Malcolm G. Parker7, Roger White7, Catherine Williamson1
1Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, England
2Department of Metabolic and Endocrine Diseases, UMC Utrecht, Utrecht, The Netherlands
3Department of Clinical & Molecular Genetics, Institute of Child Health, University College London, London
4Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany
5Department of Obstetrics and Gynecology, Sahlgrenska University Hospital/East, Goteborg, Sweden
6Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, England
7Department of Molecular Endocrinology, Institute of Reproductive and Developmental Biology, Imperial College London, London, England

Tài liệu tham khảo

Abedin, 1999, Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution, Ethn Health, 4, 35, 10.1080/13557859998173 Heinonen, 1999, Pregnancy outcome with intrahepatic cholestasis, Obstet Gynecol, 94, 189 Williamson, 2004, Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group, Br J Obstet Gynecol, 111, 676, 10.1111/j.1471-0528.2004.00167.x Laatikainen, 1977, Serum bile acids in cholestasis of pregnancy, Obstet Gynecol, 50, 313 Laatikainen, 1984, Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy, Int J Gynaecol Obstet, 22, 91, 10.1016/0020-7292(84)90019-5 Glantz, 2004, Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates, Hepatology, 40, 467, 10.1002/hep.20336 Reid, 1976, Fetal complications of obstetric cholestasis, Br Med J, 1, 870, 10.1136/bmj.1.6014.870 Reyes, 1982, The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile, Hepatology, 2, 87, 10.1002/hep.1840020114 Rioseco, 1994, Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome, Am J Obstet Gynecol, 170, 890, 10.1016/S0002-9378(94)70304-3 Ropponen, 2006, Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study, Hepatology, 43, 723, 10.1002/hep.21111 Dalen, 1974, Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters, Acta Med Scand, 195, 459, 10.1111/j.0954-6820.1974.tb08171.x Furhoff, 1974, Itching in pregnancy, Acta Med Scand, 196, 403, 10.1111/j.0954-6820.1974.tb01031.x Hirvioja, 1993, Inheritance of intrahepatic cholestasis of pregnancy in one kindred, Clin Genet, 43, 315, 10.1111/j.1399-0004.1993.tb03826.x Holzbach, 1983, Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait, Gastroenterology, 85, 175, 10.1016/S0016-5085(83)80246-7 Reyes, 1976, Idiopathic cholestasis of pregnancy in a large kindred, Gut, 17, 709, 10.1136/gut.17.9.709 Eloranta, 2001, Risk of obstetric cholestasis in sisters of index patients, Clin Genet, 60, 42, 10.1034/j.1399-0004.2001.600106.x Pauli-Magnus, 2004, Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy, Pharmacogenetics, 14, 91, 10.1097/00008571-200402000-00003 Dixon, 2000, Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking, Hum Mol Genet, 9, 1209, 10.1093/hmg/9.8.1209 Jacquemin, 1999, Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy, Lancet, 353, 210, 10.1016/S0140-6736(05)77221-4 Mullenbach, 2003, ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy, J Med Genet, 40, e70, 10.1136/jmg.40.5.e70 Mullenbach, 2005, ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy, Gut, 54, 829, 10.1136/gut.2004.058115 Painter, 2005, Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy, Eur J Hum Genet, 13, 435, 10.1038/sj.ejhg.5201355 Deleuze, 1996, Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis, Hepatology, 23, 904, 10.1002/hep.510230435 Klomp, 2004, Characterization of mutations in ATP8B1 associated with hereditary cholestasis, Hepatology, 40, 27, 10.1002/hep.20285 Strautnieks, 1997, Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24, Am J Hum Genet, 61, 630, 10.1086/515501 Makishima, 1999, Identification of a nuclear receptor for bile acids, Science, 284, 1362, 10.1126/science.284.5418.1362 Parks, 1999, Bile acids: natural ligands for an orphan nuclear receptor, Science, 284, 1365, 10.1126/science.284.5418.1365 Huber, 2002, Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters, Gene, 290, 35, 10.1016/S0378-1119(02)00557-7 Zhang, 2003, Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation, J Biol Chem, 278, 104, 10.1074/jbc.M209505200 Ananthanarayanan, 2001, Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor, J Biol Chem, 276, 28857, 10.1074/jbc.M011610200 Huang, 2003, Farnesoid X receptor activates transcription of the phospholipid pump MDR3, J Biol Chem, 278, 51085, 10.1074/jbc.M308321200 Barbier, 2003, FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity, Gastroenterology, 124, 1926, 10.1016/S0016-5085(03)00388-3 Echchgadda, 2004, Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor, Mol Pharmacol, 65, 720, 10.1124/mol.65.3.720 Denson, 2001, The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp, Gastroenterology, 121, 140, 10.1053/gast.2001.25503 Goodwin, 2000, A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis, Mol Cell, 6, 517, 10.1016/S1097-2765(00)00051-4 Li, 2005, FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade, Am J Physiol Gastrointest Liver Physiol, 288, G60, 10.1152/ajpgi.00170.2004 Landrier, 2006, The nuclear receptor for bile acids, FXR, transactivates the human organic solute transporter-alpha and -beta genes, Am J Physiol Gastrointest Liver Physiol, 290, G476, 10.1152/ajpgi.00430.2005 Wasmuth, 2007, Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene, Gut, 56, 265, 10.1136/gut.2006.092742 Belandia, 2000, Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors, J Biol Chem, 275, 30801, 10.1074/jbc.C000484200 Devarakonda, 2003, Structure of the heterodimeric ecdysone receptor DNA-binding complex, EMBO J, 22, 5827, 10.1093/emboj/cdg569 Metivier, 2003, Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter, Cell, 115, 751, 10.1016/S0092-8674(03)00934-6 Kreek, 1987, Female sex steroids and cholestasis, Semin Liver Dis, 7, 8, 10.1055/s-2008-1040559 Reyes, 2000, Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy, Ann Med, 32, 94, 10.3109/07853890009011758 Sweeney, 2006, Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy, Am J Physiol Endocrinol Metab, 290, E1313, 10.1152/ajpendo.00071.2005 Bergheim, 2006, Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers, J Lipid Res, 47, 5250, 10.1194/jlr.M500215-JLR200 Moschetta, 2004, Prevention of cholesterol gallstone disease by FXR agonists in a mouse model, Nat Med, 10, 1352, 10.1038/nm1138